Back to mobile site

Form SCHEDULE 13G/A Q32 Bio Inc. Filed by: Point72 Asset Management, L.P.

May 15, 2026 4:41 PM EDT





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
   Rule 13d-1(b)
   Rule 13d-1(c)
   Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person:  The information set forth on this cover page reflects information as of the close of business on May 14, 2026. As of March 31, 2026, the Reporting Person may have been deemed to beneficially own 0 shares of Common Stock (as defined in Item 2(a)), representing 0% of the shares of Common Stock outstanding as of such time.


SCHEDULE 13G




Comment for Type of Reporting Person:  The information set forth on this cover page reflects information as of the close of business on May 14, 2026. As of March 31, 2026, the Reporting Person may have been deemed to beneficially own 0 shares of Common Stock, representing 0% of the shares of Common Stock outstanding as of such time.


SCHEDULE 13G




Comment for Type of Reporting Person:  The information set forth on this cover page reflects information as of the close of business on May 14, 2026. As of March 31, 2026, the Reporting Person may have been deemed to beneficially own 0 shares of Common Stock, representing 0% of the shares of Common Stock outstanding as of such time.


SCHEDULE 13G



 
Point72 Asset Management, L.P.
 
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:05/15/2026
 
Point72 Capital Advisors, Inc.
 
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:05/15/2026
 
Steven A. Cohen
 
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:05/15/2026


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings

Related Entities

13G, Point72 Asset